Active Recombinant Human DSG2, Fc Chimera

• Cat.No.: DSG2-512H
• Product Overview: Recombinant Human DSG2 (Accession # CAA81226) was produced in Mouse myeloma cell line, NS0-derived.

Specification

• Source: Mammalian cells
• Species: Human
• Tag: Fc Chimera
• Predicted N Terminal: Ala49
• Form: Lyophilized from a 0.2 µm filtered solution in PBS.
• Bio-activity: Measured by the ability of the immobilized protein to support the adhesion of BUD-8 human fibroblast cells.When 3 x 10^4 cells are added to recombinant human Desmoglein-2 coated plates (10 µg/mL, 100 µL/well), approximately 50%-80% will adhere after 1 hour at 37°C. Optimal dilutions should be determined by each laboratory for each application.
• Molecular Mass: Recombinant Human DSG2, Fc Chimera has a calculated MW of 89 kDa (monomer). In SDS-PAGE migrates as 115 kDa, reducing conditions.
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).

Gene Information

• Gene Name: DSG2 desmoglein 2 [ Homo sapiens ]
• Official Symbol: DSG2
• Synonyms: DSG2; desmoglein 2; desmoglein-2; CDHF5; HDGC; cadherin family member 5; ARVC10; ARVD10; CMD1BB; MGC117034; MGC117036; MGC117037
• Gene ID: 1829
• mRNA Refseq: NM_001943
• Protein Refseq: NP_001934
• MIM: 125671
• UniProt ID: Q14126
• Chromosome Location: 18q12.1

Reviews

05/05/2021

Unmatched product superiority, professional customer service, and delivery that exceeded expectations.

02/01/2019

A truly delightful buying experience.

07/17/2018

This lab product excels in quality, backed by a customer service team that is not only friendly but also knowledgeable.

Q&As

How does Desmoglein-2 contribute to wound healing and tissue repair, and are there therapeutic implications for manipulating its activity in these processes?

Desmoglein-2 plays a role in wound healing and tissue repair by facilitating cell adhesion and migration. Manipulating its activity may have therapeutic implications for enhancing these processes.

How is the expression of Desmoglein-2 regulated, and what are the consequences of its dysregulation in the context of autoimmune diseases and skin disorders?

Desmoglein-2 expression is regulated at transcriptional and post-translational levels. Dysregulation is linked to autoimmune diseases like pemphigus, where autoantibodies target Desmoglein-2, leading to skin blistering.

Can you elaborate on the molecular structure of Desmoglein-2 and its interactions within desmosomal complexes?

Desmoglein-2 has a unique molecular structure with extracellular domains facilitating cell-cell adhesion. It interacts with other desmosomal components, such as Desmocollins and Plakoglobin, forming strong intercellular junctions.

How does Desmoglein-2 contribute to the regulation of cell signaling pathways, and are there specific pathways influenced by its interactions with other cellular components?

Desmoglein-2 participates in cell signaling, impacting pathways involved in cell adhesion, migration, and survival. Its interactions with other desmosomal components modulate signaling cascades essential for cellular function.

Can you discuss the role of Desmoglein-2 in epithelial-mesenchymal transition (EMT) and its implications for cancer invasion and metastasis?

Desmoglein-2 influences EMT, a process crucial for cancer invasion and metastasis. Changes in Desmoglein-2 expression and localization contribute to alterations in cell adhesion dynamics during EMT.